Global Anal Fistula Treatment Market to Reach $874.4 Million by 2030
The global market for Anal Fistula Treatment estimated at US$630.3 Million in the year 2022, is projected to reach a revised size of US$874.4 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030.The U.S. Market is Estimated at $188.3 Million, While China is Forecast to Grow at 4% CAGR
The Anal Fistula Treatment market in the U.S. is estimated at US$188.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$155.6 Million by the year 2030 trailing a CAGR of 4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 3.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.Select Competitors (Total 42 Featured) -
- Becton, Dickinson and Company
- biolitec AG
- Cook Medical LLC
- GEM Srl
- Johnson & Johnson
- KARL STORZ SE & Co. KG
- Medtronic PLC
- Novartis AG
- TiGenix NV
- W. L. Gore & Associates, Inc. - Medical Products Division
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton, Dickinson and Company
- biolitec AG
- Cook Medical LLC
- GEM Srl
- Johnson & Johnson
- KARL STORZ SE & Co. KG
- Medtronic PLC
- Novartis AG
- TiGenix NV
- W. L. Gore & Associates, Inc. - Medical Products Division
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 630.3 Million |
Forecasted Market Value ( USD | $ 874.4 Million |
Compound Annual Growth Rate | 4.2% |
Regions Covered | Global |